Saturday 17 October 2026
Export HLTHQ’s income statement to Excel — free account
Cue Health Inc.
HLTHQ Healthcare Health Information Services
Cue Health Inc.’s revenue for fiscal 2023 (year ended December 2023) was $70.9 million, down 85.3% from fiscal 2022.
0.00
0.00
NaN
Follow HLTHQ
| Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 3 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 6.29 | 17.01 | 17.01 | — |
Altman Z-Score |
(5.66) | 1.35 | 3.75 | — | — | — |
P/S ratio |
0.50 | 0.65 | 1.15 | 1.78 | 1.78 | — |
Altman Z″-Score (non-manufacturers) |
(9.26) | 4.95 | 7.97 | (1.19) | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Beneish M-Score |
— | (3.25) | 21.18 | — | — | — |
P/Operating CF |
(1.22) | (6.10) | 80.04 | (139.48) | (139.48) | — |
P/B ratio |
0.14 | 0.55 | 1.00 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.15 | 0.56 | 1.01 | 0.00 | 0.00 | — |
EV/Sales |
(0.65) | 0.15 | 0.47 | 2.04 | 2.04 | — |
EV/EBITDA |
0.14 | 0.00 | 1.29 | 5.49 | 5.49 | — |
EV/Operating CF |
0.33 | (0.66) | (30.46) | 7.85 | 7.85 | — |
EV/FCF |
0.29 | (0.42) | (2.30) | (5.24) | (5.24) | — |
Quick Ratio |
1.91 | 3.67 | 3.16 | 0.85 | 3.06 | — |
Current Ratio |
2.54 | 5.21 | 4.01 | 1.18 | 3.26 | — |
Net Debt/EBITDA |
0.24 | 1.54 | (1.88) | 3.10 | 0.41 | — |
Debt/Assets |
0.00% | 0.12% | 0.35% | 2.30% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.10 | 0.00 | — |
Asset Turnover |
0.14 | 0.59 | 0.98 | 0.15 | 0.00 | — |
Operating CF/Net income |
0.37 | 0.58 | (0.29) | (1.96) | 0.63 | — |
Capex/Depreciation |
(0.35) | (1.29) | (3.53) | (12.44) | (0.81) | — |
Interest Coverage |
(340.68) | (318.84) | 19.39 | (120.66) | (136.62) | — |
| (90.35%) | (30.24%) | 10.94% | 59.36% | 25.83% | — | |
| (72.21%) | (23.74%) | 5.27% | (29.94%) | 0.00% | — | |
ROIC |
(146.40%) | (38.37%) | 41.52% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(268.69%) | (39.67%) | 4.86% | (36.01%) | (92.06%) | — |
Average Days of Receivables |
6.96 | 14.16 | 61.76 | 66.28 | 11.02 | — |
Research and Development Expense of Revenue |
212.33% | 35.46% | 6.93% | 124.07% | 323.05% | — |
Selling, General and Administrative Expense of Revenue |
126.79% | 38.41% | 17.56% | 107.39% | 90.37% | — |
Intangible Assets out of Total Assets |
0.06 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
68.70% | 13.30% | 7.15% | 13.78% | 5.07% | — |
Graham Net Nets |
0.59 | 0.80 | 0.62 | (0.32) | (0.32) | — |
Graham Number |
0.00 | 0.00 | 25.33 | 0.00 | 0.00 | — |
Earnings Yield |
(1,060.87%) | (61.50%) | 15.89% | 5.88% | 5.88% | — |
Free Cash Flow Yield |
(448.24%) | (55.49%) | (17.67%) | (21.84%) | (21.84%) | — |
Revenue per Share |
0.46 | 3.27 | 11.70 | 1.41 | 0.42 | — |
Operating CF per Share |
(0.90) | (0.76) | (0.18) | 5.68 | (0.82) | — |
Capex per Share |
(0.13) | (0.43) | (2.19) | (4.79) | (0.19) | — |
Free Cash Flow per Share |
(1.03) | (1.18) | (2.37) | 0.89 | (1.01) | — |
Cash per Share |
0.53 | 1.64 | 8.02 | 7.82 | 0.91 | — |
Shareholders Equity per Share |
1.64 | 3.89 | 13.38 | 4.59 | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
1.64 | 3.89 | 13.38 | 4.59 | 0.00 | — |
Free Cash Flow |
(157.61) | (174.95) | (125.17) | 14.51 | (15.94) | — |
Working Capital |
66.90 | 299.96 | 503.09 | 27.80 | 10.75 | — |
Capital Expenditures |
(19.80) | (63.03) | (115.72) | (78.15) | (2.94) | — |
Net Current Asset Value |
20.83 | 253.07 | 436.71 | (57.71) | 15.50 | — |
EV/EBIT |
0.12 | 0.00 | 1.51 | 0.00 | 0.00 | — |
Capex to Sales |
0.28 | 0.13 | 0.19 | 3.40 | 0.44 | — |
Price to Operating Income |
0.00 | 0.00 | 3.72 | 0.00 | 0.00 | — |
| Other line items | ||||||
Depreciation/Fixed assets |
0.78 | 0.26 | 0.19 | 0.06 | 0.31 | — |
Cash ROIC |
(47.48%) | (21.34%) | (11.04%) | 6.91% | (73.88%) | — |
Accounts Receivable Turnover |
7.06 | 7.84 | 11.37 | 10.51 | 3.03 | — |
Accounts Payable Turnover |
17.11 | 14.88 | 9.06 | 1.20 | 0.00 | — |
Inventory Turnover |
2.64 | 3.87 | 4.42 | 0.24 | — | — |
Average Days of Payables |
22.13 | 7.91 | 49.11 | 582.18 | 0.00 | — |
Days of Inventory on Hand |
40.32 | 90.94 | 116.66 | 899.43 | — | — |
Average Receivables |
10.05 | 61.67 | 54.38 | 2.18 | 2.18 | — |
Average Payables |
7.43 | 22.18 | 30.53 | 12.51 | 12.51 | — |
Average Inventory |
48.12 | 85.30 | 62.62 | 62.62 | — | — |
Average Assets |
517.18 | 817.32 | 628.19 | 158.16 | 0.00 | — |
Average Common Equity |
413.37 | 641.62 | 302.68 | (79.77) | (79.77) | — |
Columns are period end dates